Comparing two microinvasive glaucoma surgeries with cataract surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the postoperative outcomes of two different microinvasive glaucoma surgery implants, MINIject and Hydrus, when performed alongside cataract surgery in patients with chronic glaucoma. Participants will be monitored for five years, with assessments including intraocular pressure measurements, fundus examinations, and ocular imaging using Optical Coherence Tomography (OCT). The study also evaluates quality of life and records any adverse events that may occur during the follow-up period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated
* Clinically eligible for both surgeries
* Subjects not anticipated to require any further surgery in the next 12 months
* Patients' age \> 18 years

Exclusion Criteria:

* Patients who do not want to make follow-ups at the department
* Angle closure, uveitic, neovascular, congenital glaucoma, iridocorneal endothelial syndrome, Axenfeld-Rieger syndrome
* Prior filtering glaucoma surgery, suprachoroidal stent, retinal surgery, corneal graft surgery or cyclophotocoagulation
* Allergy to any drugs or substances required for the protocol
* Pregnant women

Where it's running

• Medical University Graz
  Graz, Styria, Austria Recruiting

Study contacts

• Principal investigator: Ewald Lindner, Prof. — Medical University of Graz
• Study coordinator: Ewald Lindner, Prof.
• Email: ewald.lindner@medunigraz.at
• Phone: +4331638580810

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Measuring eye pressure and fluid outflow during cataract or glaucoma surgery

  This will test whether measuring eye pressure and fluid outflow during cataract or glaucoma surgery with a disposable sensor can help predict and improve recovery for adults having these operations.

  Recruiting The New York Eye & Ear Infirmary · New York, New York · NCT07425496

• Bimatoprost implant with SpyGlass intraocular lens vs timolol drops for cataract patients with glaucoma

  This study tests whether placing a bimatoprost implant together with a SpyGlass intraocular lens during cataract surgery controls eye pressure better than daily timolol drops in people with mild to moderate open‑angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · San Antonio, Texas · NCT07218796

• Combining a bimatoprost eye implant with the SpyGlass intraocular lens versus timolol eye drops for people having cataract removal

  This study will test whether placing a small bimatoprost implant with the SpyGlass intraocular lens at the time of cataract surgery better controls eye pressure than using timolol eye drops in people with mild to moderate open-angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · Houston, Texas · NCT07218783

• My Eyes, My Light — community eye screening in Char Fasson

  This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.

  Recruiting Data Yakka, Inc. · Char Fasson, Bhola · NCT07135570

• Vision screening in general practice to catch preventable sight loss in people over 70

  This project will test a GP-based vision-screening program for people aged 70 and older with at least one chronic condition to find sight problems early.

  Recruiting at 2 sites University of Copenhagen · Copenhagen, Capital Region and 1 other locations · NCT07015034

• Cataract surgery using low pressure techniques for glaucoma patients

  This study is testing a new cataract surgery method using lower pressure to see if it helps glaucoma patients have safer and better outcomes.

  Recruiting Visionair Oogzorg · Geel · NCT06712758

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.